Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Hepatitis C Infection May Increase Cardiovascular Risk

By LabMedica International staff writers
Posted on 30 Aug 2015
People infected with the Hepatitis C virus (HCV) are at risk for liver damage, but the infection may also lead to cardiovascular damage. More...


A recent study found that participants chronically infected with hepatitis C were more likely to harbor abnormal fat-and-calcium plaques inside their arteries, a condition known as atherosclerosis and a common forerunner of heart attacks and strokes.

Scientists at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) and their colleagues assessed 994 men 40 to 70 years old without overt heart disease who were followed across several institutions in Baltimore, Washington DC, Pittsburgh, Los Angeles, and Chicago. Of the 994, 613 were infected with human immunodeficiency virus (HIV), 70 were infected with both viruses and 17 were only infected with hepatitis C. Participants underwent cardiac computed tomography (CT) scans to detect and measure the amount of fat and calcium deposits inside the vessels of their hearts.

Study participants who had higher levels of circulating HCV in their blood were 50% more likely to have clogged arteries, compared with men without hepatitis C. Higher virus levels in the blood signal that the infection is not well controlled by drugs or the immune system. Poorly controlled infection, the investigators added, may lead to more inflammation throughout the body, which can fuel blood vessel damage and thus contribute to heart disease. Those infected with hepatitis C, regardless of HIV status, had, on average, 30% more disease-fueling calcified plaque in their arteries, the main driver of heart attack and stroke risk. People infected with either HIV or hepatitis C, on average, had 42% more non-calcified fatty buildup, a type of plaque believed to confer the greatest cardiac risk.

Eric Seaberg, PhD, assistant professor of epidemiology, and lead investigator, said, “We have strong reason to believe that infection with hepatitis C fuels cardiovascular disease, independent of HIV and sets the stage for subsequent cardiovascular trouble. We believe our findings are relevant to anyone infected with hepatitis C regardless of HIV status.” The authors concluded that chronic HCV infection is associated with subclinical cardiovascular disease, suggesting that HCV-infected individuals warrant vigilant cardiovascular risk assessments. The study was published on July 27, 2015, in the Journal of Infectious Diseases.

Related Links:

Johns Hopkins Bloomberg School of Public Health



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.